Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

A team of researchers, led by one of Indian origin, has found that a drug recently approved by the US Food and Drug ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and ...

Numbers released by the Heart Failure Society of America in September 2024 reveal that approximately 6.7 million Americans ...

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

When people talk about having a " broken heart," they're more often than not referring to it in the metaphorical sense. However, for some, a broken heart is a very literal, physical condition.

For a long time, there have been concerns that beta-blockers might cause mental health problems like depression, anxiety, and ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

A drug commonly used to treat high blood pressure, nifedipine, may pose more risks than previously thought, according to a ...